Key result
ARC-HBR criteria linked to ~5.2-fold higher 1-year major bleeding post-PCI, matching PRECISE-DAPT performance.
Why the study?
Proper management of bleeding risk after PCI is critical, and the recently proposed ARC-HBR criteria needed direct comparison with the PRECISE-DAPT score in Korean patients.
Do the ARC-HBR criteria and PRECISE-DAPT score demonstrate comparable accuracy in predicting 1-year bleeding and all-cause death in post-PCI patients on DAPT?
Cross-Sectional (n=1,418)
No
Do the ARC-HBR criteria and PRECISE-DAPT score demonstrate comparable accuracy in predicting 1-year bleeding and all-cause death in post-PCI patients on DAPT?
Hazard Ratio: 5.21 (95% CI 4.62–8.2)
Absolute Event Rate: 31.1% vs 6.9%
p-value: p=<0.001
The simple PRECISE-DAPT score is as effective as the more comprehensive ARC-HBR criteria for predicting 1-year bleeding and mortality after PCI, supporting its utility for tailoring DAPT duration.
Comparable predictive accuracy of ARC-HBR and PRECISE-DAPT for post-PCI bleeding; leaves open whether either should guide DAPT duration.
The proper management of bleeding risk in patients undergoing percutaneous coronary intervention (PCI) is critical. Recently, the Academic Research Consortium for High Bleeding Risk (ARC-HBR) criteria have been proposed as a standardized tool for predicting bleeding risk. We sought to compare the predictive performance of ARC-HBR criteria and the PRECISE-DAPT score for bleeding in Korean patients undergoing PCI. We recruited 1418 consecutive patients undergoing PCI from January 2012 through December 2018 (Dong-A University Medical Center, Busan, Korea). The ARC-HBR and PRECISE-DAPT scores showed a high AUC for three bleeding definitions (AUC 0.75 and 0.77 for BARC 3 to 5; AUC 0.68 and 0.71 for TIMI minor to major; AUC 0.81 and 0.82 for GUSTO moderate to severe, respectively) and all-cause death (AUC 0.82 and 0.82, respectively). When compared with the ARC-HBR score, the discriminant ability of the PRECISE-DAPT score was not significantly different for bleeding events and all-cause death. The ARC-HBR criteria and PRECISE-DAPT scores demonstrated reasonably good discriminatory capacity with respect to 1-year bleeding events in Korean patients treated with DAPT, regardless of the bleeding definition. Our findings also suggest that the simple PRECISE-DAPT score is as useful as ARC-HBR criteria in predicting bleeding and all-cause death after PCI.
No takes yet. Share an insight, caveat, or question.
Choi et al. (2021) conducted a cross-sectional in Post-percutaneous coronary intervention (PCI) on maintenance dual antiplatelet therapy (DAPT) (n=1,418). High Bleeding Risk (ARC-HBR criteria) vs. No High Bleeding Risk was evaluated on 1-year BARC 3 to 5 bleeding (HR 5.21, 95% CI 4.62-8.20, p=<0.001). The ARC-HBR criteria accurately identified post-PCI patients at high risk for 1-year major bleeding (31.1% vs 6.9%, HR 5.21), demonstrating similar overall predictive capacity to the PRECISE-DAPT score (AUC 0.75 vs 0.77).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: